Is human hepatocellular carcinoma a hormone-responsive tumor?

Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with advanced hepatocellular carcinoma (HCC). Sex hormones receptors are expressed in a significant proportion of HCC samples. Following preclinic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Maio, Massimo Di, Daniele, Bruno, Pignata, Sandro, Gallo, Ciro, Maio, Ermelinda De, Morabito, Alessandro, Piccirillo, Maria Carmela, Perrone, Francesco
Format: Artigo
Idioma:Inglês
Publicat: The WJG Press and Baishideng 2008
Matèries:
Topic Highlight
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2695908/
https://ncbi.nlm.nih.gov/pubmed/18350599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.1682
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars